Disseminated intravascular coagulation: diagnostic and therapeutic considerations

Area of Science:

• Hematology
• Internal Medicine
• Critical Care Medicine

Background:

• Disseminated intravascular coagulation (DIC) is a complex acquired coagulation disorder.
• While uncommon on general medical services, DIC is increasingly frequent due to aggressive critical care.
• Understanding DIC's pathophysiology has led to diagnostic criteria and management guidelines.

Observation:

• Hemorrhage and thrombosis are key indicators for initiating DIC therapy.
• Heparin is the primary treatment when underlying causes cannot be corrected.
• Close patient monitoring during heparin therapy is crucial.

Findings:

• Advances in understanding DIC pathophysiology enable better diagnosis and management.
• Heparin demonstrates efficacy in managing DIC, particularly when other treatments are insufficient.
• Therapeutic monitoring enhances the benefit-to-risk ratio of heparin for DIC patients.

Implications:

• Improved diagnostic criteria and management guidelines aid clinicians in treating DIC.
• Heparin therapy, when monitored, offers a viable treatment option for complex coagulation disorders.
• Further research into DIC pathophysiology may yield more targeted therapeutic strategies.